2024-10-21T08:46:33-05:00 2023-12-31 521853933 JM&M 10500 LITTLE PATUXENT PARKWAY SUITE 770 COLUMBIA MD 21044 990 2023-01-01 521736533 INFINITE LEGACY INC INFI 4102427000 1730 TWIN SPRINGS ROAD 200 BALTIMORE MD 21227 SCOTT HARTRANFT CURRENT VICE PRES. AND CFO 4102427000 2024-10-19 1 1 TINA PEACHER P01608826 4108840220 2023 2024-10-15 13:58:12Z X SCOTT HARTRANFT 1730 TWIN SPRINGS ROAD 200 BALTIMORE MD 21227 94888245 0 X WWW.INFINITELEGACY.ORG X 1990 MD TO FACILITATE THE PROCUREMENT OF ORGAN, EYE AND TISSUE DONATION IN MARYLAND, NORTHERN VIRGINIA AND WASHINGTON, DC AND TO EDUCATE PEOPLE ABOUT THE CRITICAL IMPORTANCE OF REGISTERING TO BE A DONOR. 13 12 346 327 0 0 134785 251594 52686287 75208332 61605 1292894 6900 -58399 52889577 76694421 0 26000 0 0 20459790 33735466 0 0 370237 33594752 43929689 54054542 77691155 -1164965 -996734 39722434 81503718 14689076 22880336 25033358 58623382 X WE INSPIRE COMMUNITIES IN MARYLAND, NORTHERN VIRGINIA AND WASHINGTON DC TO CREATE AN INFINITE LEGACY THROUGH ORGAN, EYE AND TISSUE DONATION. 0 1 41209640 66425150 ORGAN COORDINATION: OUR CLINCIAL STAFF RECOVER KIDNEYS, HEARTS, LIVERS, PANCREATA, INTESTINES AND LUNGS WITH TRANSPLANT SURGEON(S). ONCE RECOVERED, THESE ORGANS, ARE TRANSPORTED AND TRANSPLANTED INTO A RECIPIENT PATIENT. CLINICAL STAFF MEMBERS PERFORM AN ON-SITE REVIEW OF THE PATIENT'S CLINICAL COURSE, ARE RESPONSIBLE FOR THE CLINICAL MANAGEMENT OF ORGAN DONORS AND PROVIDE TECHNICAL SUPPORT TO THE COORDINATORS AND SURGEONS DURING THE RECOVERY PROCESS. 7243158 DONOR SERVICES COORDINATION: COORDINATORS WHO PROVIDE DONOR SERVICES RECEIVE THE INITIAL COMMUNICATION OF A POTENTIAL DONOR CASE. THEY ARE RESPONSIBLE FOR LOCAL ORGAN ALLOCATION, LOGISTICAL PLANNING, IMPORT OFFERS, TRIAGE OF REFERRALS AND LOGISTICS FOR TISSUE DONATION. DONOR SERVICES COORDINATES ALL ASPECTS OF THE PROCESS IN COLLABORATION WITH THE ORGANIZATION'S FAMILY SERVICES STAFF, TISSUE RECOVERY TEAM AND THE QUALITY ASSURANCE DEPARTMENT. 4607414 4000 FAMILY SERVICES: THE FAMILY SERVICES COORDINATOR IS RESPONSIBLE FOR COORDINATING A WIDE RANGE OF SUPPORT FOR POTENTIAL ORGAN AND TISSUE DONOR FAMILIES. THEY ESTABLISH INITIAL CONTACT WITH THE POTENTIAL DONOR FAMILY AND PROVIDE TRAUMA, GRIEF AND BEREAVEMENT SERVICES FOR THE FAMILY OR IDENTIFY HOSPITAL RESOURCES TO PROVIDE THESE SERVICES. INFORMATION IS COMMUNICATED IN AN EASILY UNDERSTOOD AND ACCURATE MANNER TO FAMILIES WHOSE ABILITY TO PROCESS INFORMATION IS IMPAIRED BY THE EMOTIONAL TRAUMATIC CIRCUMSTANCES. THE COORDINATORS OFFER SUPPORT TO POTENTIAL DONOR FAMILIES FOR AS LONG AS NECESSARY. THEY PROVIDE TWO YEARS OF AFTERCARE SUPPORT AND HANDLE ALL COMMUNICATION THAT MAY OCCURBETWEEN THE DONORS' FAMILIES AND TRANSPLANT RECIPIENTS. 4476115 22000 EDUCATION, OUTREACH, AND HOSPITAL DEVELOPMENT: THE BUSINESS DEVELOPMENT DIVISION WORKS COLLABORATIVELY WITH 68 HOSPITALS PARTNERS TO IDENTIFY AND IMPLEMENT SOLUTIONS FOR BEST PRACTICES IN SAVING LIVES THROUGH ORGAN AND TISSUE DONATION. THE COMMUNITY OUTREACH DEPARTMENT IS RESPONSIBLE FOR EDUCATING THE COMMUNITY ABOUT ORGAN, EYE AND TISSUE DONATION AND EMPOWERING THE PUBLIC TO REGISTER AS DONORS THROUGH EDUCATION AND OUTREACH, EVENTS, COMMUNITY PARTNERSHIPS, PRESENTATIONS AND GRASSROOTS INITIATIVES. THE COMMUNICATIONS & MARKETING DEPARTMENT RAISES AWARENESS ABOUT THE CRITICAL IMPORTANCE OF REGISTERING TO BE AN ORGAN AND TISSUE DONOR THROUGH MEDIA CAMPAIGNS WHICH SHARE FACTS ABOUT DONATION AND STORIES OF DONOR HEROES AND THOSE WHO RECEIVED A SECOND CHANCE AT LIFE. 3385620 7795382 TISSUE COORDINATION: THE HIGHLY TRAINED CLINICAL TEAM RECOVERS SKIN, EYES, BONES AND CARDIOVASCULAR TISSUE AND PACKAGES IT ACCORDING TO THE FOOD AND DRUG ADMINISTRATION GUIDELINES BEFORE IT IS SENT TO PROCESSORS TO SAVE AND HEAL LIVES. 1859403 987800 SKIN PROCESSING PROGRAM: WE RECOVER HIGH QUALITY ALLOGRAFT SKIN TO BE USED FOR TREATMENT IN BURN, TRAUMA AND WOUND CARE CASES. WE ALSO PROVIDES COST EFFECTIVE, SPECIFICALLY SIZED ALLOGRAFT SKIN PRODUCTS AND PROCESSING SERVICES TO OTHER THIRD-PARTY TISSUE RECOVERY PROGRAMS. 9721138 22000 8783182 62781350 1 1 0 1 0 0 0 0 0 0 1 0 0 1 1 1 1 0 0 0 0 0 0 0 1 0 0 0 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 30 0 1 346 1 0 0 0 0 0 0 0 0 0 0 0 0 X 13 12 0 0 0 0 0 0 0 1 1 0 0 1 1 1 1 1 1 1 1 0 MD X SCOTT HARTRANFT 4102427000 1730 TWIN SPRINGS RD SUITE 200 BALTIMORE MD 21227 CHARLES ALEXANDER PRESIDENT & CEO 40.00 X X 521927 0 86082 KEVIN HARLEN CHAIR 1.35 X X 0 0 0 ROBERT ATLAS VICE CHAIR 1.35 X X 0 0 0 THOMAS KAUFMAN TREASURER 1.35 X X 0 0 0 VICKIE COSBY SECRETARY 0.50 X X 0 0 0 CHRISTA GAHAGAN MEMBER 0.40 X 0 0 0 SHELLY MCDONALD-PINKETT MEMBER 0.50 X 0 0 0 DANIEL TANG MEMBER 0.40 X 0 0 0 FLAVIA WALTON MEMBER 0.40 X 0 0 0 KRISTEN JONES BRYCE MEMBER 0.50 X 0 0 0 KEITH GHEZZI MEMBER 1.35 X 0 0 0 HENRY FRANEY MEMBER 2.00 X 0 0 0 TANJALA PURNELL MEMBER 2.00 X 0 0 0 ANN BROMERY DIRECTOR OF FINANCE UNTIL 08/2023 40.00 X 313639 0 19577 LORI BRIGHAM SPECIAL ADVISOR UNTIL 06/2023 40.00 X 491113 0 30854 MEGAN VALENCIA CFO UNTIL 08/2023 40.00 X 305105 0 8334 DEBBIE WILLIAMS EXECUTIVE VP & COO 40.00 X 282179 0 67985 CARLOS FERNANDEZ-BUENO MEDICAL DIRECTOR - ORGAN RECOVERY 40.00 X 411659 0 19406 DEBORAH MCRANN VP AND CHIEF CLINICAL OFFICER 40.00 X 268630 0 59001 NATALIE HOGUE DIRECTOR OF ORGAN RECOVERY 40.00 X 225896 0 32713 KENNETH BOYD VP AND CHIEF BUSINESS DEVELOPMENT OFFICER 40.00 X 217994 0 50980 EMILY GOLDBLOOM VP AND CHIEF ADMINISTRATIVE OFFICER 40.00 X 212087 0 40499 JACLYN QUACKENBUSH VP AND CHIEF HR OFFICER 40.00 X 208829 0 64283 KAREN KENNEDY VP OF EXTERNAL AFFAIRS 40.00 X 205349 0 28108 BARBARA GORDON DIRECTOR OF QUALITY SYSTEMS 40.00 X 202391 0 27953 LESLIE REED DIRECTOR OF COMPENSATION & BENEFITS 40.00 X 184393 0 16174 TIFFANY ARRINGTON DIRECTOR OF BUSINESS INTELLIGENCE 40.00 X 181328 0 36894 4232519 0 588843 67 0 1 0 NATIONWIDE ORGAN RECOVERY TRANSPORT ALLI 3815 EAST MAIN ST ST CHARLES IL 60174 ORGAN TRANSPORT 5002567 GIFT OF LIFE DONOR PROGRAM PO BOX 13327 TD BANK PHILADELPHIA PA 19101 ORGAN PROCUREMENT 3662697 AMERICAN FOUNDATION FOR DONATION & TRANS 8154 FOREST HILL AVE STE 3 RICHMOND VA 23235 ORGAN PROCUREMENT 2031819 CENTER FOR ORGAN RECOVERY & EDUCATION 204 SIGMA DRIVE PITTSBURGH PA 15238 DONOR OPO 1789711 LIFENET HEALTH 8831 PARK CENTRAL DRIVE RICHMOND VA 23227 ORGAN PROCUREMENT 1716300 59 88246 48786 114562 251594 ORGAN COORDINATION 900099 66425150 66425150 TISSUE COORDINATION 900099 7795382 7795382 SKIN PROCESSING 900099 987800 987800 75208332 974948 974948 6900 0 6900 6900 6900 18409596 18091650 317946 317946 317946 36735 88246 102174 -65439 -65439 MISCELLANEOUS 900099 140 140 140 76694421 75208332 0 1234495 4000 4000 22000 22000 3651834 2639124 975974 36736 23194463 16828483 6131853 234127 961714 625626 327578 8510 4049293 3129020 875036 45237 1878162 1412911 445576 19675 675354 675354 89762 89762 25167 25167 187248 187248 2290184 534678 1753492 2014 274309 274309 2282503 1013161 1266311 3031 1745669 1317975 410237 17457 541143 434460 106683 357226 255067 102159 908937 120586 788351 451192 328166 119576 3450 KIDNEY PROGRAM 16076681 16076681 LIVER PROGRAM 8062816 8062816 LUNG PROGRAM 3906949 3906949 HEART PROGRAM 3127536 3127536 2927013 2667802 259211 77691155 62781350 14539568 370237 916457 4639094 6500879 14295961 334483 795477 176526 182725 15802115 10700301 4919046 5101814 17488573 46274319 9386470 10214328 39722434 81503718 8765784 14363669 5923292 8516667 14689076 22880336 X 24987630 58024651 45728 598731 25033358 58623382 39722434 81503718 X -996734 4153033 30433725 X X 0 1 X 1 0 X 234279 146659 131509 134875 251594 898916 42408426 43690999 52006463 52686287 75245067 266037242 42642705 43837658 52137972 52821162 75496661 266936158 0 1467648 846716 896527 705273 17070373 20986537 1467648 846716 896527 705273 17070373 20986537 245949621 693951 489936 211098 263280 981848 2640113 693951 489936 211098 263280 981848 2640113 140 140 43336656 44327594 52349070 53084442 76478649 269576411 0.91240 0.96950 0.00980 0.00980 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 0 0 0 0 0 0 1 25167 0 0 25167 0 PART II-B, LINE 1: INFINITE LEGACY CONTRACTS WITH COMPASS, A GOVERNMENT RELATIONS FIRM, TO ENSURE MARYLAND STATE LEGISLATORS UNDERSTAND THE COMPLEXITIES OF THE ORGAN DONATION AND TRANSPLANT SYSTEM AND SUPPORT CONSTIUENTS WAITING FOR A LIFESAVING TRANSPLANT. 10460089 5944478 4515611 385919 385919 0 4956107 4369904 586203 5101814 SECURITY DEPOSIT 103246 DUE FROM MEDICARE 3142121 OPERATING LEASE RIGHT OF USE ASSET 6811800 DEFERRED COMPENSATION ASSET 157161 10214328 OPERATING LEASE LIABILITY 8359506 DEFERRED COMPENSATION LIABILITY 157161 8516667 X 80762380 4153033 102174 4255207 76507173 187248 187248 76694421 77606081 102174 102174 77503907 187248 187248 77691155 PART X, LINE 2: INFINITE LEGACY BELIEVES THAT IT HAS APPROPRIATE SUPPORT FOR ANY TAX POSITIONS TAKEN, AND AS SUCH, DOES NOT HAVE ANY UNCERTAIN TAX POSITIONS THAT ARE MATERIAL TO THE FINANCIAL STATEMENTS OR THAT WOULD HAVE AN EFFECT ON ITS TAX EXEMPT STATUS. THERE ARE NO UNRECOGNIZED TAX BENEFITS OR LIABILITIES THAT NEED TO BE RECORDED. PART XI, LINE 2D - OTHER ADJUSTMENTS: FUNDRAISING EXPENSES 102,174. PART XII, LINE 2D - OTHER ADJUSTMENTS: FUNDRAISING EXPENSES 102,174. FAMILY FUN RUN 124981 88246 36735 20770 17399 64005 124981 88246 36735 20770 17399 64005 102174 -65439 1 LESLIE A. EBERT LEGACY OF LIFE SCHOLARSHIP 10 22000 PART I, LINE 2: INFINITE LEGACY SPONSORS A SCHOLARSHIP COMPETITION THAT RAISES AWARENESS ABOUT ORGAN DONATION AMONG THE YOUTH. FUNDS PAID FROM THE SCHOLARSHIP FOR COLLEGE TUITION ARE REMITTED DIRECTLY TO THE COLLEGE OR UNIVERSITY THAT THE STUDENT WILL BE ATTENDING. FUNDS ARE NOT PAID DIRECTLY TO THE INDIVIDUAL WINNER NOR TO ANY OTHER ENTITY. SCHOLARSHIP AMOUNTS ARE FROM $1,000 TO $5,000. MINIMAL MONITORING IS REQUIRED. X X X 1 1 0 0 0 1 0 0 0 CHARLES ALEXANDER PRESIDENT & CEO 521927 0 0 0 0 0 60993 0 25089 0 608009 0 0 0 LORI BRIGHAM SPECIAL ADVISOR UNTIL 06/2023 21338 0 61275 0 408500 0 8397 0 22457 0 521967 0 0 0 CARLOS FERNANDEZ-BUENO MEDICAL DIRECTOR - ORGAN RECOVERY 399659 0 12000 0 0 0 17325 0 2081 0 431065 0 0 0 DEBBIE WILLIAMS EXECUTIVE VP & COO 282179 0 0 0 0 0 38060 0 29925 0 350164 0 0 0 ANN BROMERY DIRECTOR OF FINANCE UNTIL 08/2023 182599 0 27040 0 104000 0 12734 0 6843 0 333216 0 0 0 DEBORAH MCRANN VP AND CHIEF CLINICAL OFFICER 268630 0 0 0 0 0 34035 0 24966 0 327631 0 0 0 MEGAN VALENCIA CFO UNTIL 08/2023 185105 0 0 0 120000 0 8334 0 0 0 313439 0 0 0 JACLYN QUACKENBUSH VP AND CHIEF HR OFFICER 208829 0 0 0 0 0 36126 0 28157 0 273112 0 0 0 KENNETH BOYD VP AND CHIEF BUSINESS DEVELOPMENT OFFICER 217994 0 0 0 0 0 35279 0 15701 0 268974 0 0 0 NATALIE HOGUE DIRECTOR OF ORGAN RECOVERY 199106 0 26790 0 0 0 9975 0 22738 0 258609 0 0 0 EMILY GOLDBLOOM VP AND CHIEF ADMINISTRATIVE OFFICER 212087 0 0 0 0 0 29088 0 11411 0 252586 0 0 0 KAREN KENNEDY VP OF EXTERNAL AFFAIRS 179094 0 26255 0 0 0 9002 0 19106 0 233457 0 0 0 BARBARA GORDON DIRECTOR OF QUALITY SYSTEMS 177709 0 24682 0 0 0 9360 0 18593 0 230344 0 0 0 TIFFANY ARRINGTON DIRECTOR OF BUSINESS INTELLIGENCE 159234 0 22094 0 0 0 8107 0 28787 0 218222 0 0 0 LESLIE REED DIRECTOR OF COMPENSATION & BENEFITS 161022 0 23371 0 0 0 7821 0 8353 0 200567 0 0 0 PART I, LINES 4A-B INFINITE LEGACY MAINTAINS A NON-QUALIFIED 457(F) DEFERRED COMPENSATION PLAN FOR THE TOP MANAGEMENT OF THE ORGANIZATION. UNDER THIS ARRANGEMENT A PORTION OF THE EMPLOYEE'S COMPENSATION IS DEFERRED AND PAYABLE AFTER 3 YEARS OF CONTINUED EMPLOYMENT. CONTRIBUTIONS TO THIS PLAN TOTALED AS FOLLOWS DURING 2023: CHIEF EXECUTIVE OFFICER $43,698 CHIEF OPERATIONS OFFICER $23,802 CHIEF CLINICAL OFFICER $22,488 CHIEF BUSINESS DEVELOPMENT OFFICER $17,919 CHIEF ADMINISTRATIVE OFFICER $17,931 CHIEF HUMAN RESOURCES OFFICER $18,346 WHEN THESE AMOUNTS ARE PAID OUT THEY ARE INCLUDED IN THE EMPLOYEE'S REPORTABLE COMPENSATION FOR THE YEAR IN WHICH THEY ARE PAID. WITHDRAWALS FROM THE PLAN ARE INCLUDED IN THE LISTED BONUS AND INCENTIVE COMPENSATION AMOUNTS. DURING 2023, NO DISTRIBUTIONS WERE MADE AGAINST THE PLAN. IN 2023, SEVERANCE PAYMENTS WERE MADE TO THE FOLLOWING INDIVIDUALS AS PART OF THE SEPARATION AGREEMENTS THAT THEY SIGNED: LORI BRIGHAM $408,500 ANN BROMERY $104,000 MEGAN VALENCIA $120,000 PART I, LINE 6 COMPENSATION INCLUDES AN INCENTIVE PAY PROGRAM. MANY DIFFERENT FACTORS ARE INCLUDED AS INCENTIVE GOALS, AND THESE GOALS ARE PREDOMINATELY PROGRAM RELATED. A COMPONENT OF THE INCENTIVE PLAN INCLUDES OPERATING FINANCIAL RESULTS. THE ORGANIZATION COMPARES TOTAL COMPENSATION (INCLUDING THE INCENTIVE PLAN) VERSUS OTHER COMPARABLE ORGANIZATIONS TO DETERMINE A FAIR COMPENSATION LEVEL. IN ADDITION, THE INDEPENDENT MEMBERS OF THE BOARD DOCUMENT ALL DELIBERATIONS AND DECISIONS REACHED WHEN DETERMINING EXECUTIVE COMPENSATION. FORM 990, PART III, LINE 3 EFFECTIVE JANUARY 1, 2023, THE LIVING LEGACY FOUNDATION OF MARYLAND MERGED WITH WASHINGTON REGIONAL TRANSPLANT COMMUNITY TO REALIZE AN EXCEPTIONAL OPPORTUNITY TO BRING TOGETHER COLLECTIVE EXPERTISE, RESOURCES AND OFFERINGS TO PROVIDE IMPROVE DONATION AND TRANSPLANT SERVICES TO THE COMMUNITIES IT SERVES. INFINITE LEGACY NOW SERVES ALMOST 10 MILLION PEOPLE IN MARYLAND, NORTHERN VIRGINIA AND WASHINGTON, DC. FORM 990, PART VI, SECTION B, LINE 11B THE FORM 990 IS REVIEWED BY THE ORGANIZATION'S CHIEF FINANCIAL OFFICER AND THE PRESIDENT/CEO, AND THE AUDIT AND COMPLIANCE COMMITTEE OF THE BOARD OF DIRECTORS. IT IS THEN DISTRIBUTED TO THE ENTIRE BOARD OF DIRECTORS BEFORE IT IS FILED WITH THE IRS. FORM 990, PART VI, SECTION B, LINE 12C ON AN ANNUAL BASIS, THE VP & CHIEF ADMINISTRATIVE OFFICER ENSURES THAT ALL BOARD MEMBERS AND STAFF HAVE COMPLETED THE CONFLICT OF INTEREST FORM, AND ALSO MAINTAINS A COPY OF EACH FORM COMPLETED. FORM 990, PART VI, SECTION B, LINE 15 DURING 2023, THE BOARD MET ABOUT THE COMPENSATION FOR THE CEO AND ALL OTHER OFFICERS, AND THEY REVIEWED COMPARABLE DATA FROM THE NEWPORT GROUP, AN EXECUTIVE COMPENSATION AND BENEFITS CONSULTING FIRM, AND THE OUTCOME WAS DOCUMENTED AND COMMUNICATED IN WRITING TO THESE LEADERS. FORM 990, PART VI, SECTION C, LINE 19 THE ORGANIZATION'S CONFLICT OF INTEREST POLICY AND FINANCIAL STATEMENTS ARE MADE AVAILABLE UPON REQUEST. FORM 990, PART XI, LINE 9: INCREASE IN NET ASSETS FROM ACQUISITION OF WASHINGTON REGIONAL TRANSPLANT 30,433,725. FORM 990, PART XII, LINE 2C: THE ORGANIZATION HAS NOT CHANGED ITS AUDIT OVERSIGHT PROCESS OR PROCESS OF SELECTION OF AN INDEPENDENT ACCOUNTANT DURING THE TAX YEAR.